TipRanks
Iovance Biotherapeutics Inc (DE:2LB)
FRANKFURT:2LB

Compare Iovance Biotherapeutics (2LB) vs. Competitors

19 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Iovance Biotherapeutics
€7.30
€5.72B
-20.31
563.82%
7 Buy
2 Hold
0 Sell
Strong Buy
Nektar Therapeutics
$73.77
$1.49B
-6.50
-27.97%
9 Buy
2 Hold
0 Sell
Strong Buy
Arcus Biosciences
$30.59
$3.11B
-6.22
82.80%
8 Buy
3 Hold
0 Sell
Moderate Buy
Immatics
$9.43
$1.14B
-4.24
-13.06%
5 Buy
0 Hold
0 Sell
Strong Buy
Nuvation Bio
$7.10
$1.81B
-11.83
38.54%
9 Buy
0 Hold
0 Sell
Strong Buy
Immunocore Holdings
$36.75
$1.53B
-164.78
-15.81%
4 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:2LB
Iovance Biotherapeutics
12.42
10.39
512.43%
NKTR
Nektar Therapeutics
43.58
-16.35
-27.28%
RCUS
Arcus Biosciences
24.44
9.96
68.78%
IMTX
Immatics
7.59
-1.80
-19.17%
NUVB
Nuvation Bio
5.14
1.37
36.34%
IMCR
Immunocore Holdings
29.71
-4.30
-12.64%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts